Dr. Suresh profile photo

Dr. Suresh

Assistant Professor

School of Allied Health Sciences & Management (SAHSM)

s.kumar@dpsru.edu.in
Google Scholar
ORCID: 0000-0001-7585-2724

Educational Qualifications

M Pharm & Ph.D

Experience

Academic / Teaching Experience

1.6 Years

Clinical / Industry Experience

8 years

Area of Specialization / Research

Medicinal chemistry, Biochemistry

Notable Publications

  1. 1.

    Ali MR, Kumar S , Bawa S et al. Development of 2‐(substituted benzylamino)‐4‐methyl‐1, 3‐thiazole‐5‐carboxylic acid derivatives as xanthine oxidase inhibitors and free radical scavengers” Chemical Biology & Drug Design , 2016; 87; 508-516. ( Impact Factor 2.8 ).

    2016
  2. 2.

    Ali MR, Kumar S , Bawa S et al. 2‐Benzamido‐4‐methylthiazole‐5‐carboxylic acid derivatives as potential xanthine oxidase inhibitors and free radical scavengers. Archiv der Pharmazie – Chemistry in life sciences, 2017; 350; , ( Impact Factor 2.3 ).

    2017
  3. 3.

    Arshad MF, Al-Otaibi F, Kumar S , Elkerdasy A, et al. Discovery of novel beta-lactam amalgamated 4-methylthiazole-5-carboxylic acid derivatives as potential antimicrobial agents. Acta Poloniae pharmaceutica- drug research, 2017; 74; 1699-1709. ( Impact Factor 0.5 )

    2017
  4. 4.

    Kumar S, Upmanu N, Afzal O, Bawa S. “Synthesis and Anti-tubercular screening of [(2-chloroquinolin-3-yl)methyl] thiocarbamide derivatives” Chemical Biology & Drug Design , 2014; 84; 522-530 . ( Impact Factor 2.8 ).

    2014
  5. 5.

    Afzal O, Kumar S , Bawa Set al. Docking based virtual screening and molecular dynamics study to identify potential monoacylglycerol lipase inhibitors. Bioorganic & Medicinal Chemistry Letters, 2014; 24; 3986-96 ( Impact Factor 2.4 ).

    2014
  6. 6.

    Arshad MF, Kumar S , Al Rohaimi AH, et al. “Synthesis of 3-chloro-4-fluorophenyl-3, 4-dichlorophenyl substituted thiocarbamide derivatives as potential anti-tubercular agents” Medicinal Chemistry Research, 2015; 24;; 24; 334–343 . ( Impact Factor 1.6 ).

    2015
  7. 7.

    Afzal O, Kumar S, Ali MR, Jaggi M, Bawa S Hit to lead optimization of a series of N-[4-(1,3-benzothiazol-2-yl)phenyl]acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity. European Journal of Medicinal Chemistry 2016 Oct 4;121:318-330. ( Impact Factor 6.5 ).

    2016
  8. 8.

    Kumar S , Agarwal R, Bawa S.“Comparative atom based 3D QSAR study of 3-nitro-1 H -1,2,4-triazole-based aliphatic and aromatic amines analogs for its anti-trypanosomal activities”. Medicinal Chemistry Research, 2015; 24; 22-31 . ( Impact Factor 1.6 ).

    2015
  9. 9.

    Kumar S, Goel N, Afzal O, M. Ali MR, Bawa S In-vitro antibacterial / antifungal screening of 2-chloroquinoline scaffold derivatives. Journal of Antibiotics Research , 2017; 1;, 1-11.

    2017
  10. 10.

    Ali MR, Kumar S , Afzal O, Bawa S. In-vitro antimicrobial screening and molecular docking studies of synthesized 2-chloro-N-(4-phenylthiazol-2-yl)acetamide derivatives. Drug Development & Therapeutics, 2015; 06; 79-87.

    2015
  11. 11.

    Goel N, Kumar S , Bawa S. NaBH 4 /I 2 mediated one-pot synthesis of 4-(substituted-anilinomethyl-3-(6-methoxy-2-naphthyl)-1-phenyl-1 H -pyrazoles and their antimicrobial screening. Bulgarian Chemical Communications . 2015; 47; 502 – 508 . ( Impact Factor 0.40 ).

    2015
  12. 12.

    Afzal O, Bawa S., Kumar S , Kumar R, Hassan MQ. Design, synthesis and evaluation of novel 2-piperidinyl quinoline chalcones/ amines as potential antidepressant agents. Letters in Drug Design & Discovery, 2013; 10; 75-85. ( Impact Factor 0.9 ).

    2013
  13. 13.

    Tonk RK, Bawa S, Chawla G, Deora GS, Kumar S , Afzal O et al. Synthesis and pharmacological evaluation of pyrazolo[4,3- c ]cinnoline derivatives as potential anti-inflammatory and antibacterial agents” European Journal of Medicinal Chemistry. 2012; 57; 176-184. ( Impact Factor 6.5 ).

    2012
  14. 14.

    Afzal O, Bawa S, Kumar S and Tonk RK. Nꞌ-([2-(Piperidin-1-yl)uinoline-3-yl]methylene) pyridine-4-carbohydrazide. Molbank, 2012 (2012), M748.

    2012
  15. 15.

    Kumar S , Kaushik D, Bawa S, Khan SA, Design, synthesis & screening of quinoline incorporated thiadiazole as a potential anticonvulsant. Chemical Biology & Drug Design , 2011; 79; 104-111 . ( Impact Factor 2.8 ).

    2011
  16. 16.

    Bawa S, Ahmad F, Kumar S , One-pot synthesis of diphenyl pyrazolylmethylanilines via reductive amination using NaBH4/I2 and their antimicrobial screening, Monatshefte fur Chemie – Chemical Monthly . 2011; 142; 637-642. ( Impact Factor 1.5 ).

    2011
  17. 17.

    Kumar S , Bawa S, Drabu S, Kaushik D, Synthesis and in-vitro antimicrobial activity of secondary and tertiary amines bearing 2-chloro-6-methylquinoline. Archiv der Pharmazie- Chemistry in life sciences, 2011; 344; 474-480. (Impact Factor 2.3 ).

    2011
  18. 18.

    Kumar S , Bawa S, Drabu S, H. Gupta, Machwal L, Kumar R, Synthesis, antidepressant and antifungal evaluation of novel 2-chloro-8-methylquinoline amine derivatives. European Journal of Medicinal Chemistry, 2011; 46; 670-675. ( Impact Factor 6.5 ).

    2011
  19. 19.

    Kumar S , Bawa S, Drabu S, Panda BP. Design and synthesis of 2-chloroquinoline derivatives as non-azoles antimycotic agents. Medicinal Chemistry Research , 2011; 20;1340-1348. ( Impact Factor 1.5 ).

    2011
  20. 20.

    Kaushik D, S. A. Khan, G. Chawla and Kumar S, N ’-[(5-chloro-3-methyl-1-phenyl-1 H -pyrazol-4-yl)methylene] 2/4-substituted hydrazides: Synthesis and anticonvulsant activity. European Journal of Medicinal Chemistry, 2010; 45; 3943-3949. ( Impact Factor 6.5 ).

    2010
  21. 21.

    Kumar S , Bawa S,, Drabu S, Kumar R, Machawal L. Synthesis and in -vivo anticonvulsant evaluation of 2-chloroquinolinyl –hydrazone derivatives. Acta Poloniae Pharmaceutica-Drug Research , 2010; 67; 567-573. ( Impact Factor 0.5 ).

    2010
  22. 22.

    Kumar S , Bawa S, Drabu S, Kumar R, Panda BP. New 2-chloro-7-methylquinoline amine analogues as possible antimycotic agents. Latin American Journal of Pharmacy , 2010; 29; 968-975. ( Impact Factor 0.4 ).

    2010
  23. 23.

    Mishra R, Kumar R, Kumar S , Majeed J, et al. Synthesis and in vitro antimicrobial activity of some triazole derivatives. Journal of the Chilean Chemical Society , 2010; 55; 283-286. ( Impact Factor 0.562).

    2010
  24. 24.

    Jasinski JP, Pek AE, Kumar CSC, Yathirajan HS, Kumar S . N -[(2-Chloro-3-quinolyl)methyl]-4-fluoroaniline. Acta Crystallographica Section E , E66 ( 2010 ) 2548-2549. ( Impact Factor 0.4 ).

    2010
  25. 25.

    Bawa S & Kumar S , Synthesis of Schiffs bases of 8-methyl-tetrazolo[1,5-a]quinoline as potential anti-inflammatory and antimicrobial agents. Indian Journal of Chemistry , Sec-B, 2009; 48; 142-145. ( Impact Factor 0.5 ).

    2009
  26. 26.

    Ali MR, Kumar S , Bawa S “Development of thiazole-5-carboxylate derivatives as selective inhibition of monoacylglycerol lipase as a target in Cancer” Mini-Reviews in Medicinal Chemistry, 2019;19(5): 410-423. ( Impact Factor 2.6 )

    2019
  27. 27.

    Kumar S , Bawa S, Drabu S. “N -[(2-chloro-6-methylquinolin-3-yl)methyl]-aniline, (A short note). Molbank. ( 2009 ) M618.

    2009
  28. 28.

    Bawa S, Ahmad F, Kumar S. 3-Chloro-4-fluoro-N-([3-(4-methoxyphenyl)-1-phenyl-1H-pyrazol- 4-yl]methyl) aniline. Molbank , 4 ( 2009 ) M640.

    2009
  29. 29.

    Bawa S, Kumar S , Drabu S, Kumar R, Synthesis and antimicrobial activity of 2-chloro-6-methylquinoline hydrazone derivatives. Journal of Pharmacy & Bioallied Sciences , 2009; 01; 27-31.

    2009
  30. 30.

    Bawa S, Kumar S , Drabu S, Panda BP, Kumar R, Synthesis and antimicrobial activity of 2-chloroquinoline incorporated pyrazoline derivatives. Journal of Pharmacy & Bioallied Sciences , 2009; 01; 32-36.

    2009
  31. 31.

    Arshad MF, Alam A, Kumar S et al Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents. Molecules 2022; 27; 3994-. ( Impact Factor 4. 9 )

    2022
  32. 32.

    Kashyap A, Kumar S , Dutt R. A Review on Structurally Diversified Synthesized Molecules as Monoacylglycerol Lipase Inhibitors and their Therapeutic uses. Current Drug Research Reviews . 2022; 14; 96-115. ( Impact Factor 2.1 )

    2022
  33. 33.

    Kumar S, Agarwal R. “Next generation tyrosine kinase inhibitor (TKI): Afatini b”. Recent Patents on Anti-cancer Drug Discovery . 2014; 0 9; 382-394. ( Impact Factor 2. 5 )

    2014
  34. 34.

    Afzal O , Kumar S , Haider MR, Ali MR, Kumar R, Bawa S. A review on anticancer potential of bioactive heterocycle quinoline. European Journal of Medicinal Chemistry . 2015; 97; 871-910 ( Impact Factor 6.5 ).

    2015
  35. 35.

    Kumar S , Bawa S, Drabu S, Kumar R, Gupta H. “Biological Activities of Pyrazoline Derivatives –A Recent Development.” Recent Patents on Anti-Infective Drug Discovery, 2009; 4; 154-164.

    2009
  36. 36.

    Kumar S , Bawa S, Drabu S, Gupta H. Biological Activities of Quinoline Derivatives.” Mini-Reviews in Medicinal Chemistry , 2009; 09; 1648-1654. ( Impact Factor 2.6 )

    2009
  37. 37.

    Gupta H, Sharma A, Kumar S, Roy SK, E-Tongue: A Tool for Taste Evaluation.” Recent Patents on Drug Delivery & Formulation 2010; 0 4; 82-89.

    2010
  38. 38.

    Bawa S, Kumar S , Drabu S, Kumar R “Structural modification of quinoline based antimalarial agents- Recent developments” Journal of Pharmacy & Bioallied Sciences . 2010; 02; 64-73

    2010
  39. 39.

    Indian Patent Office-Delhi, Appl. No, 2506/DEL/2013 ( Title: Substituted Thiourea derivatives as Antitubercular agents ). Abandoned

    2013
  40. 40.

    Indian Patent Office-Delhi, Appl. No, 1043/DEL/2014 (Title: Novel 1, 3-Diaryl Pyrazole Compounds and their use in inflammatory related disorders). Abandoned

    2014
  41. 41.

    “Synthesis and anticonvulsant activity of hydrazones bearing 2-chloroquinoline moiety” AICTE sponsor National Seminar on Recent Advances in Pharmaceutical Science , 7 th -9 th August, 2008, MSIP, Janakpuri, Delhi .

    2008
  42. 42.

    “Synthesis and In-vivo evaluation of antidepressant properties of some new N-[(2-chloro-8-methylquinolin-3-yl)methyl]-(substituted)-aniline”. Medchem Europe , 23-25 February 2009. Berlin, Germany, Europe .

    2009
  43. 43.

    “Synthesis of N-[(2-chloro-7-methylquinolin-3-yl)methyl]-(substituted)–anilines /butan-1-amine/ cyclohexamine as possible antimycotic agents”. Canadian Society for Pharmaceutical Sciences (CSPS) 12 th Annual International Symposium , June 3-6, 2009. Ontario, Canada.

    2009
  44. 44.

    “Design and synthesis of N -[(2-chloro-6-methylquinolin-3-yl)methyl]-(substituted)–anilines/butan-1-amine/cyclohexamine as possible antimycotic agents”. AICTE sponsor National Seminar on Emerging Trends in Pharmaceutical Science , 2009, Jamia Hamdard, Delhi (1 st Prize)

    2009
  45. 45.

    “Synthesis & Antifungal Activity of Substituted-N-[(2-chloroquinolin-3-yl)methyl]-N-methylaniline a Structural Analogues of Butenafine.” 3 rd European Conference on Chemistry for Life Sciences Linking Chemistry with Biological activity , September 2-5, 2009, Frankfurt am Main, Germany .

    2009
  46. 46.

    03 Days workshop on “ Advances in computer aided drug discovery & design methods ” from 4-6 August’2008 held at MIET, Meerut, UP.

    2008
  47. 47.

    Two weeks UGC Networking Training Course under Module B-1 on “ Computer Aided Drug Design: Hands-o Workshop ” from 28 th January to 9 th February 2013 at UIPS, Panjab University, Chandigarh,

    2013
  48. 48.

    02 Days workshop on “ Drug Approval Process in USFDA ” from 5-6 December 2017 at TTA Sun Pharma & MSU Baroda

    2017

Awards & Achievements

  • UGC-GATE Fellowship

  • UGC-JRF (PhD)

  • CSIR-RA